These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1008080)

  • 1. Current concepts in the management of malignant melanoma.
    Lichtenfeld JL
    Am J Med Sci; 1976; 272(2):185-95. PubMed ID: 1008080
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chemotherapy of malignant melanomas].
    Gallmeier WM
    Haematol Blood Transfus; 1978; 21():293-302. PubMed ID: 367896
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of chemotherapy and immunotherapy on tumor-specific immunity in melanoma.
    Mitchell MS; Mokyr MB; Davis JM
    J Clin Invest; 1977 Jun; 59(6):1017-26. PubMed ID: 863999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Results in the use of immunochemotherapy in patients with cutaneous malignant melanoma].
    Calbo L; Gorgone S; Palmeri R; Salibra M; Melita P
    Chir Ital; 1983 Aug; 35(4):519-25. PubMed ID: 6680859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant melanoma (stage IIIB): a pilot study of adjuvant chemo-immunotherapy.
    Paterson AH; McPherson TA; Willans DJ
    Cancer Treat Rep; 1978 Apr; 62(4):571-3. PubMed ID: 350395
    [No Abstract]   [Full Text] [Related]  

  • 6. [Possibilities of immunotherapy in malignant melanoma].
    Lewis MG
    Hautarzt; 1978 Dec; 29(12):619-24. PubMed ID: 363650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant chemoimmunotherapy stage I/II malignant melanoma.
    Knost JA; Reynolds V; Greco FA; Oldham RK
    J Surg Oncol; 1982 Mar; 19(3):165-70. PubMed ID: 7040820
    [No Abstract]   [Full Text] [Related]  

  • 8. The survival of patients with malignant melanoma receiving BCG with or without chemotherapy.
    Green MD; MacKay IR; Buckley JC; Coates AS
    Aust N Z J Surg; 1979 Jun; 49(3):335-9. PubMed ID: 289374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fotemustine in the treatment of metastatic malignant melanoma. Overall analysis of results].
    Pathol Biol (Paris); 1990 Oct; 38(8):876-80. PubMed ID: 2274396
    [No Abstract]   [Full Text] [Related]  

  • 10. [Chemotherapy of malignant melanoma].
    Karakousis CP
    Chirurg; 1986 Oct; 57(10):606-11. PubMed ID: 3792110
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experience with adjuvant chemoimmunotherapy with DTIC and BCG in malignant melanoma (author's transl)].
    Pullmann H; Muth M
    Z Hautkr; 1982 Feb; 57(4):294-7. PubMed ID: 7080583
    [No Abstract]   [Full Text] [Related]  

  • 12. [Adjuvant chemotherapy in malignant melanoma after pretherapeutic sensitivity testing].
    Zaumseil RP; Wohlrab W; Fiedler H; Wozniak KD
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(5):721-4. PubMed ID: 6172340
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemotherapy of unresectable or recurrent metastatic malignant melanomas: an update.
    Block JB; Tabbarah H; Isacoff W; Drakes TP
    J Dermatol Surg Oncol; 1979 Feb; 5(2):118-23. PubMed ID: 762295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of immunochemotherapy in malignant melanoma].
    Duchková H; Richter J; Kubíková M; Peska J; Ragan J; Vohryzková E; Hrivnáková J; Kvasnicka J
    Cesk Dermatol; 1980 Aug; 55(4):277-80. PubMed ID: 7407970
    [No Abstract]   [Full Text] [Related]  

  • 15. [Current results with surgery and adjuvant chemotherapy in malignant melanoma].
    Mechl Z; Kopecný J
    Arch Geschwulstforsch; 1986; 56(5):367-71. PubMed ID: 2429631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Letter: Chemoimmunotherapy of malignant melanoma.
    N Engl J Med; 1975 Jan; 292(3):159-60. PubMed ID: 1196343
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunological aspects in the treatment of malignant melanoma].
    Cascinelli N; Vaglini M; Rovini D; Orefice S; Marolda R; Veronesi U
    Minerva Med; 1982 Apr; 73(18):1233-40. PubMed ID: 7078802
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunotherapy for recurrent malignant melanoma: efficacy of BCG in prolonging the postoperative disease-free interval and survival.
    Gutterman JU; Richman SP; McBride CM; Burgess MA; Bartold SL; Kennedy A; Gehan EA; Mavligit G; Hersh EM
    Recent Results Cancer Res; 1978; 68():359-62. PubMed ID: 752870
    [No Abstract]   [Full Text] [Related]  

  • 19. Tumour regression and survival of patients with disseminated malignant melanoma treated with chemotherapy and specific active immunotherapy.
    Hedley DW; McElwain TJ; Currie GA
    Eur J Cancer (1965); 1977 Oct; 13(10):1169-73. PubMed ID: 923614
    [No Abstract]   [Full Text] [Related]  

  • 20. Chemotherapy of malignant melanoma.
    Benjamin RS
    World J Surg; 1979 Jul; 3(3):321-8. PubMed ID: 382646
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.